Patents by Inventor Meltsje De Hoop

Meltsje De Hoop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210170033
    Abstract: The invention describes novel conjugates of formula (I) of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein allowing a reversible release of the pharmaceutical agent depending on the glucose concentration.
    Type: Application
    Filed: November 30, 2018
    Publication date: June 10, 2021
    Inventors: Stefan PETRY, Elisabeth DEFOSSA, Michael PODESCHWA, Volker DERDAU, Hans MATTER, Nis HALLAND, Kaihui HU HE, Matthias DREYER, Maximilian BIELOHUBY, Melissa BESENIUS, Meltsje DE HOOP
  • Patent number: 8642259
    Abstract: The present invention relates to methods for identifying substances capable of influencing the activity of a target molecule affecting cellular proliferation.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: February 4, 2014
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Sabine Gratzer, Meltsje De Hoop, Bernhard Mai
  • Publication number: 20130189714
    Abstract: The invention refers to methods for detecting and/or quantifying the interaction of platelets or platelet surface molecules with an interaction partner, methods for detecting and/or quantifying the capability of a test substance to modulate the interaction of platelets or platelet surface molecules with interaction partners and articles or manufacture.
    Type: Application
    Filed: September 19, 2011
    Publication date: July 25, 2013
    Applicant: SANOFI
    Inventors: Meltsje De Hoop, Klaus Lindauer, Ulrike Lukasczyk, Horst Blum, Thomas Langer, Marion Zerlin
  • Publication number: 20040092474
    Abstract: The present invention relates to methods for identifying substances capable of influencing the activity of a target molecule affecting cellular proliferation.
    Type: Application
    Filed: July 23, 2003
    Publication date: May 13, 2004
    Applicant: Aventis Pharma GmbH
    Inventors: Sabine Gratzer, Meltsje De Hoop, Bernhard Mai